IL85031A - Lyophilized aspoxicillin preparation and its manufacture - Google Patents

Lyophilized aspoxicillin preparation and its manufacture

Info

Publication number
IL85031A
IL85031A IL85031A IL8503188A IL85031A IL 85031 A IL85031 A IL 85031A IL 85031 A IL85031 A IL 85031A IL 8503188 A IL8503188 A IL 8503188A IL 85031 A IL85031 A IL 85031A
Authority
IL
Israel
Prior art keywords
aspoxicillin
preparation
manufacture
lyophilized
lyophilized preparation
Prior art date
Application number
IL85031A
Other languages
English (en)
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of IL85031A publication Critical patent/IL85031A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL85031A 1987-01-14 1988-01-05 Lyophilized aspoxicillin preparation and its manufacture IL85031A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62006868A JPS63174927A (ja) 1987-01-14 1987-01-14 抗菌性凍結乾燥製剤

Publications (1)

Publication Number Publication Date
IL85031A true IL85031A (en) 1992-07-15

Family

ID=11650214

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85031A IL85031A (en) 1987-01-14 1988-01-05 Lyophilized aspoxicillin preparation and its manufacture

Country Status (18)

Country Link
US (1) US4966899A (fr)
EP (1) EP0278243B1 (fr)
JP (1) JPS63174927A (fr)
KR (1) KR930001830B1 (fr)
CN (1) CN1024754C (fr)
AT (1) ATE61222T1 (fr)
AU (1) AU597463B2 (fr)
CA (1) CA1308358C (fr)
DE (1) DE3861866D1 (fr)
DK (1) DK15088A (fr)
ES (1) ES2031930T3 (fr)
FI (1) FI89454C (fr)
GR (1) GR3001565T3 (fr)
HK (1) HK63592A (fr)
HU (1) HU197985B (fr)
IE (1) IE60049B1 (fr)
IL (1) IL85031A (fr)
SG (1) SG60292G (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048263T3 (es) * 1988-11-01 1994-03-16 Sanol Arznei Schwarz Gmbh Composicion liofilizada de mdm y metodo para su fabricacion.
EP0758651B1 (fr) * 1994-05-02 2002-09-11 Shionogi & Co., Ltd. Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production
US8252228B1 (en) * 2008-10-13 2012-08-28 Abbott Cardiovascular Systems Inc. Methods for sterilizing carriers for treatment of a kidney
CN102372727A (zh) * 2010-08-10 2012-03-14 海南美好西林生物制药有限公司 一种阿扑西林钠的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733404A (en) * 1970-09-04 1973-05-15 Squibb & Sons Inc Antibacterial composition containing alpha-aminobenzyl penicillins
US4053609A (en) * 1975-09-12 1977-10-11 Tanabe Seiyaku Co., Ltd. Penicillins and processes for preparing the same
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
GB1539510A (en) * 1976-08-23 1979-01-31 Beecham Group Ltd Injectable compositions
JPS5640686A (en) * 1979-09-11 1981-04-16 Tanabe Seiyaku Co Ltd Purification of penicillin derivative
CA1242699A (fr) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone et ses derives

Also Published As

Publication number Publication date
DK15088D0 (da) 1988-01-13
KR880008812A (ko) 1988-09-13
HK63592A (en) 1992-08-28
AU1022688A (en) 1988-07-21
DK15088A (da) 1988-07-15
FI89454C (fi) 1993-10-11
FI880027A0 (fi) 1988-01-06
EP0278243B1 (fr) 1991-03-06
ES2031930T3 (es) 1993-01-01
CN1034131A (zh) 1989-07-26
HU197985B (en) 1989-07-28
CA1308358C (fr) 1992-10-06
SG60292G (en) 1992-09-04
HUT46212A (en) 1988-10-28
GR3001565T3 (en) 1992-11-23
US4966899A (en) 1990-10-30
ATE61222T1 (de) 1991-03-15
DE3861866D1 (de) 1991-04-11
JPS63174927A (ja) 1988-07-19
AU597463B2 (en) 1990-05-31
IE880049L (en) 1988-07-14
EP0278243A1 (fr) 1988-08-17
FI880027A (fi) 1988-07-15
IE60049B1 (en) 1994-05-18
CN1024754C (zh) 1994-06-01
JPH053847B2 (fr) 1993-01-18
FI89454B (fi) 1993-06-30
KR930001830B1 (ko) 1993-03-15

Similar Documents

Publication Publication Date Title
HK1048058A1 (zh) 肝臟選擇性的藥用活性物
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
ZA885192B (en) Pharmaceutical preparations
GB8927546D0 (en) Process for the production of biologically active tgf-beta
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
GR3007202T3 (fr)
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
IL85031A (en) Lyophilized aspoxicillin preparation and its manufacture
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
EP0209843A3 (fr) Composés de benzylpipérazine, sa préparation, composition pharmaceutique et utilisation
EP0189587A3 (en) Method of sterilizing recombinant microorganism
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees